Show results for
Refine by
Clinical Trial Equipment Supplied In Austria
8 equipment items found
Manufactured by:Aposcience AG based inVienna, AUSTRIA
The target population are those over 700,000 patients worldwide who undergo reperfusion treatment for acute ST-elevation myocardial infarction. If APO-1 (APOSECTM) proves effective in clinical trials, the market potential is estimated at 1 – 2 billion Euros ...
Manufactured by:ViennaLab Diagnostics GmbH based inVienna, AUSTRIA
Determination of BRAF V600 mutational status is recommended in metastatic colorectal cancer (mCRC) at the same time as RAS mutational status for prognostic assessment (and/or potential selection for clinical trials). Testing of patients with metastatic melanoma or advanced non-small cell lung cancer for BRAF V600 mutations prior to treatment is recommended, as ...
Manufactured by:Aposcience AG based inVienna, AUSTRIA
The company expects that products derived from PBMCs will have a significant impact in the care for millions of patients who are afflicted by poorly healing wounds (diabetic foot ulcers, ischemic ulcerations, pressure ulcers) and therefore present a very important market opportunity. If efficacy can be demonstrated in clinical trials, a turnover of well over 1 ...
by:Hookipa Pharma Inc. based inVienna, AUSTRIA
The immune system is the body’s natural defense mechanism against pathogens. Our proprietary technology is capable of targeting and treating disease with a tailored immune response. Our science is based on a novel and highly differentiated delivery platform based on arenaviruses, a family of naturally-occurring ...
Manufactured by:OncoQR ML GmbH based inBreitenfurt, AUSTRIA
Lead candidate TYG100 (formerly OQR100, out-licensed to TYG oncology Ltd.) is an “Active Checkpoint Control Immunotherapy (ACCI)” for the treatment of gastroenterological cancers such as pancreatic, stomach, colon, and gastro-esophageal cancer. The immunogen of TYG100 contains a small part of G17 (little ...
Manufactured by:Nuvonis based inVienna, AUSTRIA
Vero cells have been used for producing viral vaccines for humans ever since microcarrier- based cell culture processes were developed in the 1970s. WHO has recommended the use of well characterized cell substrates back in 1998 (WHO Technical Report Series 878; Expert Committee on Biological Standardization). Due to its stability and well-documented performance regarding the quality and quantity ...
by:SK-Telemed GmbH based inVienna, AUSTRIA
Proper treatment of early stages can significantly reduce the number of heavy cases and hospitalizations. Show2Doc allows virtual care with possibility of full scope outpatient treatment with no visits to the clinic: convenient task manager, simple video calls, timely Live chat, doctors prescriptions, medication management, patient diary, vitals monitoring, scheduling and much more. Daily ...
Manufactured by:Adamo Robot based inMadrid, SPAIN
The world’s first collaborative robot that treats MSDs with compressed air. For Rehabilitation Centers and Hospitals – Clinics or Sport Clubs. ADAMO is a robotic medical device capable of aiding in the diagnosis of back pain injuries and delivering contactless treatment using temperature-controlled pressurized air. ADAMO can help reduce patient recovery times, waiting lists, and ...